XOMAP — XOMA Royalty Corporation
NASDAQ · Healthcare · Biotechnology
$24.97
+$0.00 (+0.00%)
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ. It is led by Owen P. Hughes Jr., based in 2200 Powell Street, EmeryVille, CA, United States, 94608, with about 14 employees. XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Latest reported XOMAP revenue for 2025-09-30 was $9.4M. Net income was $25.6M. Revenue was down 28.8% from 2025-06-30 to 2025-09-30. XOMAP currently screens at trailing P/E 25.4.
Use this XOMAP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XOMAP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XOMAP SEC filings page. Lician reads the product cache first so this HTML stays unique to XOMA Royalty Corporation even when a live quote feed is slow.
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMAP Key Statistics
Market Cap
$0.00M
Volume
359
Previous Close
$24.97
Day Range
$24.97 – $24.97
P/E Ratio
25.39
EPS
-$1.65
Revenue
$28.49M
Net Income
-$13.82M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+498.7%
Profit Margin
-48.5%
Employees
14
XOMAP Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $28.49M | $4.76M | $6.03M | $38.16M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$13.82M | -$40.83M | -$17.10M | $15.80M |
| EPS (Diluted) | -$1.65 | -$4.04 | -$1.98 | $0.65 |
Total Assets
$221.28M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$101.65M
Operating Cash Flow
-$13.75M
Free Cash Flow
$0.00
XOMA Royalty Corporation Company Information
- CEO & Director
- Owen P. Hughes Jr.
- Headquarters
- 2200 Powell Street, EmeryVille, CA, United States, 94608
- Website
- www.xoma.com
- Phone
- 510 204 7200
- IPO / Founded
- 2020-12-16
- Sector
- Healthcare
- Industry
- Biotechnology